ScienceDaily (Mar. 24, 2008) — Research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.
Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment